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Introduction: Inappropriate use of antibiotics leads to increased levels of bacterial resistance
making it difﬁcult to treat upper respiratory tract infections. The appropriate use of these
drugs has a fundamental role in controlling resistance and in success of treatment of child-
hood infections. Therefore, the aim of this study was to assess the prescription and use of
antibiotics for Brazilian children.
Methods: The use of antibiotics in 160 children was monitored in two Primary Health Centers
by questionnaires administered to parents and caregivers that assessed the social, demo-
graphic and clinical conditions of the children. Furthermore, the antibiotic use pattern was
ascertained in these children and compared to the recommendations of the Brazilian and
international guidelines.
Results: The use of these drugs had an inverse relationship with children breast-fed to six
months of age, showing that breast-fed children had a tendency to use less of these drugs.
There was great variability in the amoxicillin doses used for upper respiratory infections
ranging from 8.2 to 91.9mg/kg/day. The doses used in most treatments were far below the
doses recommended in the Brazilian and international guidelines (50% and 97%, respec-
tively).
Conclusion: Although there are guidelines for the use of these medications, compliance is
still very low, leading to under dosage and therapeutic failures. It is essential for pediatri-
cians to be aware of and comply with the guidelines, avoid personal decisions and takemeasures based on strong clinical evidence. The proper use of these medications, in addi-
tion to greater therapeutic success, decreases the possibility of the appearance of resistant
microorganisms.
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Table 1 – Social and demographic characteristics of the
children using antibiotics.
Variable n=160 %
Gender
Female 81 50.63
Male 79 49.38
Age
0–36 months 75 46.88
37–72 months 51 31.88
73–108 months 34 21.25
Breast-feeding (up to six months)
No 33 20.63
Yes 127 79.38
Children resident in the same household
1 86 53.75
2 53 33.13
3 16 10.00
4 4 2.50
5 1 0.63
Previous antibiotic use (last six months)
Yes 103 64.37
No 57 35.63braz j infect d i s .
ntroduction
ntibiotics prescription for children has been a cause of
oncern throughout the world. Their excessive use in non-
stablished infections or in infections with viral etiology has
een the concern of many authors.1–4
The use of these drugs in infections with viral etiology is
ot only ineffective but has also served as a form of selective
ressure for the appearance of increasingly resistant microor-
anisms. As an example, Streptococcus pneumoniae, the main
ause of upper respiratory tract infections, has increased the
evel of resistance to penicillins by 20–33%.5,6
Creech et al.7 showed that the presence ofmethicillin resis-
ant Staphylococcus aureus (MRSA) in nasal cavities of children
ncreased from 0.8% to 9% from 2001–2005. The reasons for
he increase in bacterial resistance levels are closely linked
o the improper use of antibiotics. The greatest reasons for
nappropriate use of these drugs in children are pressure from
he parents to prescribe antibiotics, difﬁculty in differenti-
ting the etiology (bacterial or viral) of these infections and
specially improper dosage as the guidelines are not followed
roperly.8–10
A study published in 2011 by the CDC (Centers for Disease
ontrol and Prevention) also conﬁrmed the direct relationship
etween improper antibiotic use and increase in bacteria
esistance levels. Antibiotic consumption in a population of 18
illion people was studied for eight years. Despite a decrease
n the mean number of antibiotic prescriptions, antibiotics
onsumption was directly related to increased levels of resis-
ance to S. pneumoniae and the greater the consumption, the
reater the level of resistance found.5
To tackle bacterial resistance, the World Health Orga-
ization proposed, among numerous interventions, that
rescribers adopt and use protocols or guidelines based
n strong evidence for the use of antibiotics for commu-
ity infections.11 Adopting these guidelines standardizes
reatments, minimizes dosage mistakes, avoids individ-
al decisions and prioritizes decisions based on clinical
vidence.12 Recent studies have shown that not adopting
uidelines has led to antibiotic prescription mistakes in pedi-
trics in terms of dose or duration.10,13
Thus the objective of the present study was to assess
he use of antibiotics in children, regarding the suitability of
ndication and dose, and compare them with the guideline
ecommendations for acute respiratory infections.
aterials and methods
his is a cross-sectional study, carried out by administering a
uestionnaire with closed questions to parents or caregivers
f children aged 0–9 years who were prescribed antibiotics in
rimary Health Centers in the municipality of Sorocaba, São
aulo state (Brazil) over 12 months. Sorocaba has a population
f 596,000 inhabitants andHDI (HumanDevelopment Index) of
.828 child mortality index of 13.5 deaths under one for every
000 live births. To collect the information, two PrimaryHealth
enters that attend 12% of the population of the municipality
ere chosen.14The instrument sought social, demographic and clinical
information of the children and their caregivers and informa-
tion on the medical diagnosis and the antimicrobial therapy
used. The instrument was designed based on a literature
review of studies on the use of medications, and was previ-
ously tested and validated.10,15
Parents or caregivers of children aged 0–9 years who
received prescriptions containing antibiotics at Primary
Health Centers and agreed to participate in the study were
interviewed.
The data were collected over 12 months and included
results from 160 children. The study was approved by the
Committee for Ethics in Research at the University of Soro-
caba (# 003/06). Anthropometric assessment was carried out
with measurements of weight and height to assess the use
mg/kg/day of the antibiotics used.
The prescriptions of antimicrobial medications used were
compared with the guidelines of the Brazilian Society of
Pediatrics16 and the American Academy of Pediatrics.17–19
Statistical analysis was performed using the software
Bioestat 5.3. The social and demographic data were treated
descriptively in frequency tables. Analysis of variance
(ANOVA) and Fisher’s exact test were used, and the level of
signiﬁcance was set at 5%.
Results
The average age of children enrolled in this study was
45.6 months, 49.7± 30.6 months for females and 41.4± 28.6
months for males (Z-test, p=0.082) (Table 1).
Age was segmented into three groups; the majority of the
participants were in the youngest age-group of 0–36 months.
Fig. 1 shows these results as an almost perfect straight line
(R2 = 0.99).
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Table 2 – Previous antibiotic use (last six months) and relationship with social and demographic characteristics studied.
Variables Previous antibiotic use (last six months) RR (95% CI) p-Value
Yes n. (prevalence) No n. (prevalence)
Gender 0.223
Male 60 (75.9) 19 (24.1) 1
Female 54 (66.6) 27 (33.3) 1.14 (0.93–1.38)
Other children resident in the same household 0.861
No 62 (72.1) 24 (27.9) 1
Yes 52 (70.3) 22 (29.7) 1.02 (0.84–1.25)
Low-birth weight 0.779
No 95 (73.1) 35 (26.9) 1
Yes 12 (70.6) 5 (29.4) 1.03 (0.74–1.43)
Breast-feeding (up to six months) <0.0001
No 22 (66.6) 11 (33.3) 1
Yes 35 (27.6) 92 (72.4) 2.41 (1.66–3.50)
RR, relative risk; CI, conﬁdence interval.
46,88%
31,88%
21,24%
R² = 0,9905
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
0 to 36 months 37 to 72 months 73 to 108 months
infectious diseases are less prevalent.Fig. 1 – Antibiotic use in children aged 0–108 months.
Information about previous antibiotic use provided by the
parents or caregivers is showed in Table 2. Gender, living
with other children in the same household, and low-birth
weight (less than 2.500 g) were not associated with previ-
ous antibiotic use (Fisher’s Exact test, p>0.05). Breast-feeding
(up to six months) was signiﬁcantly associated (Exact Fisher
test, p<0.0001) with antibiotic use. Lack of breast-feeding was
strongly associated to greater consumption of these medica-
tions (OR=5.27; 2.31–11.96).Table 3 shows the diagnoses established. Pharyngitis and
tonsillitis was more prevalent among the 3–6 year-old aged
group (37–72 months).
Table 3 – Diagnoses distribution among different age groups of
Age group (months) 0–36
Diagnosis n (%)
Pharyngitis and tonsilitis 14 (27.45)
Flu and viruses 14 (66.67)
Undeﬁned respiratory infections 26 (65.00)
Otitis 12 (70.59)
Pneumonias 2 (40.00)
Sinusitis 2 (15.38)
Urinary tract infections 2 (50.00)
Other 3 (33.33)
Total 46.88%Table 4 shows the distribution of antibiotic classes used
by children enrolled in the present study in comparison to
distributions reported by Marra et al.20 and Kozyrskyj et al.21
Penicillins were the most commonly prescribed antibiotic as
well as in the aforementioned studies.
Fig. 2 shows the distribution of amoxicillin dosages used to
treat upper respiratory infections (n=79) in the present study.
Table 5 shows the percentage of treatments with dosages
below the recommendations of the Brazilian and American
guidelines. There are a large number of treatments that did
not reach 50mg/kg/day (Brazilian guideline) and almost none
of the dosages reached the recommendations of the American
Academy of Pediatrics (80–90mg/kg/day).
Discussion
The study sample had balanced distribution of male and
female children, predominantly aged less than 36 months.
Other studies using the same methodology have indicated
the same trend, because as age advances the immune system
becomesmoremature, better hygiene habits are practiced and
20–22In addition to current use of antibiotics by the children, the
assessment instrumentusedalso inquired theparents or care-
givers about antibiotic use in the last six months. The authors
children (n=160).
37–72 73–108 Total
n (%) n (%) (%)
23 (45.10) 14 (27.45) 31.88%
4 (19.05) 3 (14.29) 13.13%
8 (20.00) 6 (15.00) 25.00%
4 (23.53) 1 (5.88) 10.63%
2 (40.00) 1 (20.00) 3.13%
6 (46.15) 5 (38.46) 8.13%
2 (50.00) 0 (0.00) 2.50%
2 (22.22) 4 (44.44) 5.63%
31.88% 21.25% 100.00%
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Table 4 – Distribution of antibiotic classes used.
Antibiotic classes Present study Marra et al.20 Kozyrskyj et al.21
Penicillins 73.13% 51.02% 58.76%
Cephalosporins 10.63% 15.11% 10.65%
Macrolides 4.38% 25.89% 16.49%
Sulfonamides 7.50% 7.00% 8.71%
Other 4.38% 0.91% 5.38%
Used doses
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bserved frequent and repeated use of this class of drugs. Pre-
ious antibiotic consumption was not related to gender, other
hildren resident in the same household or low birth weight.
owever, absence of breast-feedingwas associatedwith a ﬁve-
old increase in the consumption of these medications by the
hildren.
Durationof breast-feeding and the amount ofmilk ingested
ave been related to the emergency of respiratory diseases in
hildhood. Chantry et al.23 stated that children breast-fed for
t least six months had 1.6% likelihood of having pneumococ-
al pneumonia while in not breast-fed children this chance
as fourfold greater–very similar data to those reported in the
resent study. Some studies have shown that the immuno-
ogical role of maternal milk is not limited to transferred
ntibodies but it may also be associated to inhibition of bac-
erial colonization mediated by casein.24,25
The increased index of pharyngitis and tonsillitis wasmore
requent in 3–6 year-old children and it can be explained
y the exposure of the children to the school environments,
ropitious for contamination and propagation of upper respi-
atory tract infections. Upper respiratory tract infections
re streptococcal infections transmitted by physical con-
act between contaminated hands of sick children with the
pper respiratory tract of healthy individuals. Contagion is
avored in closed environments, such as day care centers and
chools.26
Table 5 – Treatments with dosage below the recommendations
Diagnosis Pharyngi
Dosages below 50mg/kg/day (Brazilian guidelines)18 5
Dosages below 80mg/kg/day (American guidelines)19–21 9
URI, upper respiratory infections.er respiratory infections treatment (n=79).
Other data worth highlighting are the large number of
respiratory diagnosis without topographic deﬁnition of the
infection focus (undeﬁned respiratory infections), represent-
ing 25% of all cases, of which 65% were in children aged 0–3
years. The difﬁculty in referring symptoms in this age group
may have contributed to this large proportion.
About 13% of the prescriptions were written for medical
diagnosis of ﬂu and viruses, conditions where it is known to
be unresponsive to antibiotics. There are plenty of studies in
the literature showing the inefﬁcacy of these drugs for these
conditions as prophylactic agents.21,22,26,27 Exaggerated and
uncontrolled use of antibiotics directly favors the appearance
of resistant microorganisms.28
The present study assessed the use of different antibiotic
classes in the treatment of upper respiratory tract infections
in children. The results were compared with two similar stud-
ies. Penicillin was the most prescribed, especially amoxicillin,
the drug of choice for respiratory infections in pediatrics.
Similar results have been found in a recently published
study.29 Although the data distribution was very similar to the
studies presented, greater frequency of penicillin-containing
prescriptions was clearly observed in the present study com-
pared to other two studies (p=0.0003 for Marra et al.20 and
p=0.001 for Kozyrskyj et al.21). This difference has been
explained because no macrolide antibiotics were available
in the municipal center so that the prescribers insisted on
of the Brazilian and American guidelines.
tis and tonsilitis Otitis Sinusitis All URI
1.02% 37.50% 61.54% 50.00%
7.96% 93.75% 100.00% 97.44%
i s . 20
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penicillin and greatly increased its use. In the participating
Primary Health Centers, the only macrolide available was
erythromycin that, although having a very similar spectrum
to azithromycin has uncomfortable dosage as it requires to
be administered four times daily to children under the age
of ten. The possibility of prescribing azithromycin in those
centers would offer a more convenient option for physicians,
and greater comfort for the parents.30 The literature reports
that repeating the same drugs for recurrent upper respiratory
tract infections is determinant in selecting resistant microor-
ganisms, which can be avoided by using other therapeutic
options.31–33
Regarding the therapeutics used to treat upper respiratory
infections (pharyngitis, tonsillitis, otitis and sinusitis), which
accounted for 50.65% of the participants of the present study,
the Brazilian literature has established amoxicillin at the dose
of 50mg/kg/day as the preferred regimen for children with-
out complications. For relapses and comorbidities, the dose
should be increased to 90mg/kg/day.16 In contrast, guidelines
from the American Academy of Pediatrics has recommended,
especially for sinusitis and otitis, starting treatment with high
dose amoxicillin at 90mg/kg/day because of the many reports
of S. pneumoniae resistant to conventional treatment.17–19
In the present study, the computed amoxicillin doses
to treat upper respiratory infections were calculated based
on the prescription and weight of the children at the
time of the consultation. On average, the dose used was
47.2± 13.7mg/kg/day for all upper respiratory infections. For
sinusitis, the average doses were 46.1± 13.7mg/kg/day, for oti-
tis 53.2± 11.8mg/kg/day, and for pharyngitis and tonsillitis
45.5± 15.1mg/kg/day.
There was great disparity in treatments used with dosages
ranging from 8.2 to 91.2mg/kg/day. When compared to the
Brazilian guideline,16 39 doses (50.0%) were below the rec-
ommended standards (50mg/kg/day) and 20 prescriptions
(25.64%) did not even reach 40mg/kg/day. According to the
guidelines of the American Academy of Pediatrics17–19 only
two treatments (2.6%) of the present study have reached the
recommended dosages (80 and 90mg/kg/day).
Sub-inhibitory amoxicillin concentrations at the infection
site has led to bacterial adaptive phenomena, known as per-
sistence, that ﬁrst inhibit bacterial growth without eradicating
the infection. In addition to the direct effect on the therapeutic
failure, studies have shown that sub-inhibitory concentra-
tions induce mutation phenomena, induction and expression
of bacterial resistance promoting genes. Studies have shown
that these genes, in addition to resistance to the drug itself,
further promote cross resistance, that is, to amoxicillin and
other beta-lactam antibiotics.34,35
The various percentage of treatments with dosages below
those recommended by the Brazilian and American guide-
lines were described. There is a large number of treatments
that do not reach 50mg/kg/day (Brazilian guideline)16 and
almost none of the dosages reached those recommended by
the American Academy of Pediatrics (80–90mg/kg/day).17–19
This study detected a great number of unnecessary pre-
scriptions that lead to increased antibiotic exposure to
non-pathogenic microorganisms. This exposure favors the
appearance of bacterial resistance genes and had exposed
these children to adverse effects caused by antibiotics, such13;17(3):332–337
as hypersensitive reactions that are very common with the
use of beta-lactam antibiotics.
Another important result of the present study was the
lack of standardization in antibiotic prescriptions. Even
considering the Brazilian guideline, on average, 60% of the
prescriptions had dosages below those recommended and
showed lack of standardization in the prescriptions. The
Brazilian government has produced and made available ref-
erence material for rational medication use, based on strong
clinical evidence36 in addition to innumerable pediatric and
infectious diseases societies that make their guidelines avail-
able on their websites. Thus prescribers need to consult
and use these guides, bringing economy to the health care
network and better clinical results in tackling infections in
pediatrics.37–39
Conclusion
In the present study many pediatric prescriptions were found
with errors regarding the indication and dosage of antimi-
crobials. In spite of many publications warning about the
undesirable consequences of antibiotics use in undeﬁned sit-
uations or undeﬁned viral etiology, this study found a great
number of unnecessary prescriptions, leading to increased
exposure of antibiotic in cases of nonpathogenic microor-
ganisms. This conduct favors the appearance of bacterial
resistance genes in addition to exposing these children to
the antibiotic adverse effects, such as hypersensitive reactions
that is very common with the use of these antibiotics.
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